Surface antigen expression in malignant sublines derived from hybrid cells of low malignancy.
D000818:Animals; D000937:Antigen-Antibody Reactions; D000941:Antigens / Q000032:analysis*; D000956:Antigens, Viral / Q000032:analysis; D002286:Carcinoma, Ehrlich Tumor / Q000276:immunology; D002460:Cell Line; D002462:Cell Membrane / Q000276:immunology*; D002471:Cell Transformation, Neoplastic; D002875:Chromosomes / Q000276:immunology; D002999:Clone Cells; D046508:Culture Techniques; D003582:Cytogenetics; D003601:Cytotoxicity Tests, Immunologic; D000939:Epitopes; D005347:Fibroblasts; D005455:Fluorescent Antibody Technique; D006383:Hemadsorption Inhibition Tests; D006822:Hybrid Cells / Q000276:immunology*; D007104:Immune Adherence Reaction; D007106:Immune Sera; D007519:Isoantigens / Q000032:analysis*; D007739:L Cells; D051379:Mice; D008979:Moloney murine leukemia virus / Q000276:immunology; D009368:Neoplasm Transplantation
D000941:Antigens; D000956:Antigens, Viral; D000939:Epitopes; D007106:Immune Sera; D007519:Isoantigens